EDIT vs REG
Editas Medicine Inc (EDIT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
REG does not have a complete income-statement cache yet.
EDIT currently screens at market cap $375.2M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the EDIT and REG stock pages for the full models.
Not investment advice.